Compare NVAX & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | LMB |
|---|---|---|
| Founded | 1987 | 1901 |
| Country | United States | United States |
| Employees | N/A | 1400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1996 | 2014 |
| Metric | NVAX | LMB |
|---|---|---|
| Price | $9.40 | $92.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $10.78 | ★ $130.00 |
| AVG Volume (30 Days) | ★ 3.8M | 118.6K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.26 | 46.02 |
| EPS | ★ 2.53 | 2.21 |
| Revenue | ★ $682,162,000.00 | $518,781,000.00 |
| Revenue This Year | $58.91 | $27.83 |
| Revenue Next Year | N/A | $13.63 |
| P/E Ratio | ★ $3.68 | $42.02 |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $5.01 | $63.02 |
| 52 Week High | $10.63 | $154.04 |
| Indicator | NVAX | LMB |
|---|---|---|
| Relative Strength Index (RSI) | 60.93 | 59.32 |
| Support Level | $8.01 | $88.21 |
| Resistance Level | $10.42 | $101.21 |
| Average True Range (ATR) | 0.51 | 6.03 |
| MACD | 0.04 | 0.45 |
| Stochastic Oscillator | 93.41 | 74.59 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.